Published in Br J Cancer on February 09, 2010
Biomarkers of epithelial-mesenchymal transition in squamous cell carcinoma. J Dent Res (2012) 1.69
Bmi-1 Regulates Snail Expression and Promotes Metastasis Ability in Head and Neck Squamous Cancer-Derived ALDH1 Positive Cells. J Oncol (2010) 1.13
GOLPH3 overexpression correlates with tumor progression and poor prognosis in patients with clinically N0 oral tongue cancer. J Transl Med (2012) 1.12
Identification of stem cells that maintain and regenerate lingual keratinized epithelial cells. Nat Cell Biol (2013) 1.10
High CIP2A immunoreactivity is an independent prognostic indicator in early-stage tongue cancer. Br J Cancer (2011) 0.99
Cancer stem cell markers in head and neck squamous cell carcinoma. Stem Cells Int (2013) 0.97
Bmi-1, c-myc, and Snail expression in primary breast cancers and their metastases--elevated Bmi-1 expression in late breast cancer relapses. Virchows Arch (2011) 0.96
Bmi1 drives stem-like properties and is associated with migration, invasion, and poor prognosis in tongue squamous cell carcinoma. Int J Biol Sci (2015) 0.96
Head and neck cancer stem cells. J Dent Res (2011) 0.94
Expression and prognostic value of c-Myc and Fas (CD95/APO1) in patients with pancreatic cancer. Int J Clin Exp Pathol (2014) 0.93
Oncogenic roles of Bmi1 and its therapeutic inhibition by histone deacetylase inhibitor in tongue cancer. Lab Invest (2014) 0.92
Phosphorylation of Nanog is essential to regulate Bmi1 and promote tumorigenesis. Oncogene (2013) 0.91
Nuclear BMI-1 expression in laryngeal carcinoma correlates with lymph node pathological status. World J Surg Oncol (2012) 0.88
Prognostic significance of Flotillin1 expression in clinically N0 tongue squamous cell cancer. Int J Clin Exp Pathol (2014) 0.88
Oral epithelial stem cells in tissue maintenance and disease: the first steps in a long journey. Int J Oral Sci (2013) 0.87
Recently identified biomarkers that promote lymph node metastasis in head and neck squamous cell carcinoma. Cancers (Basel) (2011) 0.86
The translational significance of epithelial-mesenchymal transition in head and neck cancer. Clin Transl Med (2014) 0.86
Stem cell-related proteins C-KIT, C-MYC and BMI-1 in juvenile nasopharyngeal angiofibroma--do they have a role? Virchows Arch (2010) 0.83
Aldehyde dehydrogenase activity is a cancer stem cell marker of tongue squamous cell carcinoma. Mol Med Rep (2012) 0.83
Polycomb complex protein BMI-1 promotes invasion and metastasis of pancreatic cancer stem cells by activating PI3K/AKT signaling, an ex vivo, in vitro, and in vivo study. Oncotarget (2016) 0.82
Cancer-associated fibroblasts provide a suitable microenvironment for tumor development and progression in oral tongue squamous cancer. J Transl Med (2015) 0.80
BMI-1, a promising therapeutic target for human cancer. Oncol Lett (2015) 0.79
Phosphatase and tensin homolog overexpression decreases proliferation and invasion and increases apoptosis in oral squamous cell carcinoma cells. Oncol Lett (2014) 0.79
Targeting BMI1(+) Cancer Stem Cells Overcomes Chemoresistance and Inhibits Metastases in Squamous Cell Carcinoma. Cell Stem Cell (2017) 0.77
Glutaminolysis and carcinogenesis of oral squamous cell carcinoma. Eur Arch Otorhinolaryngol (2015) 0.76
The Stem Cell Marker Bmi-1 Is Sensitive in Identifying Early Lesions of Carcinoma ex Pleomorphic Adenoma. Medicine (Baltimore) (2015) 0.75
Lingual Epithelial Stem Cells and Organoid Culture of Them. Int J Mol Sci (2016) 0.75
Stress-triggered atavistic reprogramming (STAR) addiction: driving force behind head and neck cancer? Am J Cancer Res (2016) 0.75
Prognostic Value of Cancer Stem Cell Markers in Head and Neck Squamous Cell Carcinoma: a Meta-analysis. Sci Rep (2017) 0.75
Expression Analysis of Genes Involved in the RB/E2F Pathway in Astrocytic Tumors. PLoS One (2015) 0.75
Role of B lymphoma Mo-MLV insertion region 1 in the oncogenic behavior of retinoblastomas. Mol Vis (2013) 0.75
Vimentin is a potential prognostic factor for tongue squamous cell carcinoma among five epithelial-mesenchymal transition-related proteins. PLoS One (2017) 0.75
Does securin expression have significance in prognostication of oral tongue cancer? A pilot study. Eur Arch Otorhinolaryngol (2016) 0.75
The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat Cell Biol (2000) 15.78
c-MYC: more than just a matter of life and death. Nat Rev Cancer (2002) 6.73
Bmi-1 promotes neural stem cell self-renewal and neural development but not mouse growth and survival by repressing the p16Ink4a and p19Arf senescence pathways. Genes Dev (2005) 5.78
Bmi-1 collaborates with c-Myc in tumorigenesis by inhibiting c-Myc-induced apoptosis via INK4a/ARF. Genes Dev (1999) 5.35
Bmi1 is essential for cerebellar development and is overexpressed in human medulloblastomas. Nature (2004) 4.82
Epigenetic signatures of stem-cell identity. Nat Rev Genet (2007) 3.56
The Bmi-1 oncogene induces telomerase activity and immortalizes human mammary epithelial cells. Cancer Res (2002) 3.16
Bmi-1 is a novel molecular marker of nasopharyngeal carcinoma progression and immortalizes primary human nasopharyngeal epithelial cells. Cancer Res (2006) 3.12
Reduced c-Myc signaling triggers telomere-independent senescence by regulating Bmi-1 and p16(INK4a). Proc Natl Acad Sci U S A (2006) 2.06
Overexpression of Bmi-1 oncoprotein correlates with axillary lymph node metastases in invasive ductal breast cancer. Breast (2004) 2.01
Cutting edge: polycomb gene expression patterns reflect distinct B cell differentiation stages in human germinal centers. J Immunol (2000) 1.83
Histopathological prognosticators in oral and oropharyngeal squamous cell carcinoma. Oral Oncol (2005) 1.77
Clinical and histopathologic independent prognostic factors in oral squamous cell carcinoma: a retrospective study of 334 cases. J Oral Maxillofac Surg (2008) 1.73
Elevated Bmi-1 expression is associated with dysplastic cell transformation during oral carcinogenesis and is required for cancer cell replication and survival. Br J Cancer (2006) 1.71
Increased polycomb-group oncogene Bmi-1 expression correlates with poor prognosis in hepatocellular carcinoma. J Cancer Res Clin Oncol (2007) 1.44
Snail-associated epithelial-mesenchymal transition promotes oesophageal squamous cell carcinoma motility and progression. J Pathol (2008) 1.42
Prognostic significance of microscopic and macroscopic extracapsular spread from metastatic tumor in the cervical lymph nodes. Oral Oncol (2002) 1.38
Immortalization of primary human prostate epithelial cells by c-Myc. Cancer Res (2005) 1.30
Snail-dependent and -independent epithelial-mesenchymal transition in oral squamous carcinoma cells. J Histochem Cytochem (2006) 1.25
Elective neck treatment versus observation in patients with T1/T2 N0 squamous cell carcinoma of oral tongue. Oral Oncol (2005) 1.24
Prognostic value of Bmi-1 oncoprotein expression in NSCLC patients: a tissue microarray study. J Cancer Res Clin Oncol (2008) 1.21
Early stage carcinoma of oral tongue: prognostic factors for local control and survival. Oral Oncol (2000) 1.10
Stem cell protein BMI-1 is an independent marker for poor prognosis in oligodendroglial tumours. Neuropathol Appl Neurobiol (2008) 1.10
Molecular mediators of metastasis in head and neck squamous cell carcinoma. Head Neck (2005) 1.07
Cadherin-catenin complex and transcription factor Snail-1 in spindle cell carcinoma of the head and neck. Virchows Arch (2008) 1.06
Predictive value of histopathologic parameters in early squamous cell carcinoma of oral tongue. Oral Oncol (2007) 0.99
The incidence of lymph node micrometastases in patients pathologically staged N0 in cancer of oral cavity and oropharynx. Oral Oncol (2002) 0.95
Epithelial-mesenchymal transition downregulates laminin alpha5 chain and upregulates laminin alpha4 chain in oral squamous carcinoma cells. Histochem Cell Biol (2008) 0.94
Bmi-1 is induced by the Epstein-Barr virus oncogene LMP1 and regulates the expression of viral target genes in Hodgkin lymphoma cells. Blood (2006) 0.93
Altered E-cadherin/beta-catenin expression in oral squamous carcinoma with and without nodal metastasis. Oral Dis (2007) 0.90
Distinct site-specific oncoprotein overexpression in head and neck squamous cell carcinoma: a tissue microarray analysis. Anticancer Res (2003) 0.89
Potential involvement of MYC- and p53-related pathways in tumorigenesis in human oral squamous cell carcinoma revealed by proteomic analysis. J Proteome Res (2008) 0.83
Expression of C-Myc mRNA in squamous cell carcinoma of the tongue. J Surg Oncol (2007) 0.83
Matrix metalloproteinases, tissue inhibitor of matrix metalloproteinase-1, and laminin-5 gamma2 chain immunolocalization in gingival tissue of endotoxin-induced periodontitis in rats: effects of low-dose doxycycline and alendronate. J Periodontol (2007) 0.82
Correlation of clinical, histological, and cytokeratin profiles of squamous cell carcinoma of the oral tongue with prognosis. Int J Surg Pathol (2007) 0.82
WT-1 is required for early kidney development. Cell (1993) 7.05
TGFbeta2 knockout mice have multiple developmental defects that are non-overlapping with other TGFbeta knockout phenotypes. Development (1997) 6.31
Regulation of cell fate decision of undifferentiated spermatogonia by GDNF. Science (2000) 5.44
Defects in enteric innervation and kidney development in mice lacking GDNF. Nature (1996) 3.82
Treatment of severe refractory autoimmune hemolytic anemia in B-cell chronic lymphocytic leukemia with alemtuzumab (humanized CD52 monoclonal antibody). Leukemia (2007) 3.33
Extending the phenotype of recurrent rearrangements of 16p11.2: deletions in mentally retarded patients without autism and in normal individuals. Eur J Med Genet (2009) 2.65
Early organogenesis of the kidney. Pediatr Nephrol (1987) 2.60
A digital atlas of breast histopathology: an application of web based virtual microscopy. J Clin Pathol (2004) 2.40
Tumour markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines for clinical use. Eur J Cancer (2007) 2.36
Appearance and distribution of collagens and laminin in the early mouse embryo. Dev Biol (1980) 2.27
Vasculogenesis and angiogenesis in embryonic-stem-cell-derived embryoid bodies. Development (1988) 2.12
Isolation of bone from muscles prevents the development of experimental callus-like heterotopic bone. A study of the interaction of bone and muscle in new bone formation. Clin Orthop Relat Res (1994) 2.08
Does anyone survive pancreatic ductal adenocarcinoma? A nationwide study re-evaluating the data of the Finnish Cancer Registry. Gut (2005) 2.07
Glial-cell-line-derived neurotrophic factor is required for bud initiation from ureteric epithelium. Development (1997) 2.05
Merosin, a tissue-specific basement membrane protein, is a laminin-like protein. Proc Natl Acad Sci U S A (1990) 1.93
Evaluation of CA 19-9 as a serum tumour marker in pancreatic cancer. Br J Cancer (1986) 1.91
Expression of HER-2/neu gene and protein in salivary duct carcinomas of parotid gland as revealed by fluorescence in-situ hybridization and immunohistochemistry. Histopathology (2003) 1.89
Clinical utility of biochemical markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines. Eur J Cancer (2003) 1.86
A truncated laminin chain homologous to the B2 chain: structure, spatial expression, and chromosomal assignment. J Cell Biol (1992) 1.84
Tumor markers in pancreatic cancer: a European Group on Tumor Markers (EGTM) status report. Ann Oncol (2009) 1.78
Sinonasal tubulopapillary low-grade adenocarcinoma. Histopathological, immunohistochemical and ultrastructural features of poorly recognised entity. Virchows Arch (2003) 1.68
Leucocyte nadir as a marker for chemotherapy efficacy in node-positive breast cancer treated with adjuvant CMF. Br J Cancer (1999) 1.67
Cell death induced by dexamethasone in lymphoid leukemia is mediated through initiation of autophagy. Cell Death Differ (2009) 1.67
Human laminin M chain (merosin): complete primary structure, chromosomal assignment, and expression of the M and A chain in human fetal tissues. J Cell Biol (1994) 1.57
Serum tumour markers CA 15-3, TPA, TPS, hCGbeta and TATI in the monitoring of chemotherapy response in metastatic breast cancer. Scand J Clin Lab Invest (2001) 1.47
Redo bypass surgery to the infrapopliteal arteries for critical leg ischaemia. Eur J Vasc Endovasc Surg (2001) 1.47
Gastrointestinal cancer-associated antigen CA 19-9 in histological specimens of pancreatic tumours and pancreatitis. Br J Cancer (1986) 1.45
Tumour marker antigen CA125 in pancreatic cancer: a comparison with CA19-9 and CEA. Br J Cancer (1986) 1.44
The prognostic value of preoperative serum levels of CA 19-9 and CEA in patients with pancreatic cancer. Br J Cancer (1994) 1.44
Cribriform adenocarcinoma of the tongue: a hitherto unrecognized type of adenocarcinoma characteristically occurring in the tongue. Histopathology (1999) 1.43
Myocardial function and postmortem myocardial histology in children given anthracycline therapy for cancer. Pediatr Hematol Oncol (1994) 1.41
CEA, CA 19-9 and CA 72-4 improve the diagnostic accuracy in gastrointestinal cancers. Anticancer Res (2002) 1.36
The MDM2 promoter polymorphism SNP309T-->G and the risk of uterine leiomyosarcoma, colorectal cancer, and squamous cell carcinoma of the head and neck. J Med Genet (2005) 1.34
Dual origin of glomerular basement membrane. Dev Biol (1984) 1.33
Tenascin-C expression in invasion border of early breast cancer: a predictor of local and distant recurrence. Br J Cancer (1998) 1.32
Serum CA 50 as a tumor marker in pancreatic cancer: a comparison with CA 19-9. Int J Cancer (1987) 1.30
Identification of target genes in laryngeal squamous cell carcinoma by high-resolution copy number and gene expression microarray analyses. Oncogene (2006) 1.26
Comparison of a new tumour marker CA 242 with CA 19-9, CA 50 and carcinoembryonic antigen (CEA) in digestive tract diseases. Br J Cancer (1991) 1.25
Virtual microscopy. J Clin Pathol (2004) 1.24
Structure of the human macrophage MARCO receptor and characterization of its bacteria-binding region. J Biol Chem (1998) 1.23
Expression of cyclooxygenase-2 in human transitional cell carcinoma of the urinary bladder. Am J Pathol (2001) 1.22
Tumor markers in colorectal cancer, gastric cancer and gastrointestinal stromal cancers: European group on tumor markers 2014 guidelines update. Int J Cancer (2013) 1.21
Gene expression profiling of ameloblastoma and human tooth germ by means of a cDNA microarray. J Dent Res (2002) 1.19
Bacteriologic findings in peritonsillar abscesses in young adults. Clin Infect Dis (1993) 1.18
Ki-67, p53, Er-receptors, ploidy and S-phase as prognostic factors in T1 node negative breast cancer. Acta Oncol (1997) 1.17
Pancreatic carcinomas deposit laminin-5, preferably adhere to laminin-5, and migrate on the newly deposited basement membrane. Am J Pathol (1997) 1.16
BMP-4 affects the differentiation of metanephric mesenchyme and reveals an early anterior-posterior axis of the embryonic kidney. Dev Dyn (2000) 1.16
Cyclooxygenase-2 expression correlates with poor prognosis in pancreatic cancer. J Clin Pathol (2006) 1.14
Muscle-eye-brain disease: a neuropathological study. Ann Neurol (1997) 1.12
Elevation of free beta subunit of human choriogonadotropin and core beta fragment of human choriogonadotropin in the serum and urine of patients with malignant pancreatic and biliary disease. Cancer Res (1992) 1.11
Initial differentiation of the metanephric mesenchyme is independent of WT1 and the ureteric bud. Dev Genet (1999) 1.11
Stem cell protein BMI-1 is an independent marker for poor prognosis in oligodendroglial tumours. Neuropathol Appl Neurobiol (2008) 1.10
Clear cell malignant myoepithelioma of the salivary glands. Histopathology (1996) 1.10
Expression of the cell surface-associated glycoprotein, fibronectin, in the early mouse embryo. Dev Biol (1979) 1.09
Benign cementoblastoma in a primary lower molar, a rarity. Dentomaxillofac Radiol (2007) 1.08
Non-invasive (intracapsular) carcinoma ex pleomorphic adenoma: recognition of focal carcinoma by HER-2/neu and MIB1 immunohistochemistry. Histopathology (2005) 1.07
Primary structure and expression of a novel human laminin alpha 4 chain. FEBS Lett (1995) 1.07
Identification of a neurite outgrowth-promoting domain of laminin using synthetic peptides. FEBS Lett (1989) 1.07
Differential regulation of two sets of mesonephric tubules by WT-1. Development (1997) 1.06
Prognostic role of CIP2A expression in serous ovarian cancer. Br J Cancer (2011) 1.06
Differentiation and vascularization of the metanephric kidney grafted on the chorioallantoic membrane. Dev Biol (1983) 1.06
Tumour-associated trypsin inhibitor, TATI, in patients with pancreatic cancer, pancreatitis and benign biliary diseases. Br J Cancer (1986) 1.06
Epithelial and stromal syndecan-1 expression as predictor of outcome in patients with gastric cancer. Int J Cancer (2001) 1.05
Crystal structure of human erythrocyte carbonic anhydrase C. 3. Molecular structure of the enzyme and of one enzyme-inhibitor complex at 5-5 A resolution. J Mol Biol (1967) 1.05
Cervical Barrett's esophagus: a common complication of gastric tube reconstruction. J Pediatr Surg (1990) 1.05
Variability in B-cell antigen expression: implications for the treatment of B-cell lymphomas and leukemias with monoclonal antibodies. Hematol J (2001) 1.05
Promotion of seminomatous tumors by targeted overexpression of glial cell line-derived neurotrophic factor in mouse testis. Cancer Res (2001) 1.05
The origin of the glomerular endothelium. Cell Differ (1982) 1.04
Epithelial syndecan-1 expression is associated with stage and grade in colorectal cancer. Oncology (2005) 1.03
CA 242, a new tumour marker for pancreatic cancer: a comparison with CA 19-9, CA 50 and CEA. Br J Cancer (1994) 1.03
Artificial neural networks applied to survival prediction in breast cancer. Oncology (1999) 1.02
Prognostic value of Ki-67 expression, ploidy and S-phase fraction in patients with pancreatic cancer. Anticancer Res (1996) 1.01
High CIP2A immunoreactivity is an independent prognostic indicator in early-stage tongue cancer. Br J Cancer (2011) 0.99
Assessment of proliferative activity using the MIB1 antibody help to distinguish polymorphous low grade adenocarcinoma from adenoid cystic carcinoma of salivary glands. Pathol Res Pract (1997) 0.99
Extracellular matrix and epithelial differentiation of Wilms' tumor. Am J Pathol (1985) 0.99
Tumour-associated trypsin inhibitor (TATI) in human ovarian cyst fluid. Comparison with CA 125 and CEA. Br J Cancer (1987) 0.98
Basal lamina glycoproteins laminin and type IV collagen are assembled into a fine-fibered matrix in cultures of a teratocarcinoma-derived endodermal cell line. Exp Cell Res (1982) 0.97
C3d fragment of complement interacts with laminin and binds to basement membranes of glomerulus and trophoblast. J Cell Biol (1986) 0.97
Pre- and postjunctional modulation of cholinergic neuroeffector transmission by adenine nucleotides. Experiments with agonist and antagonist. Acta Physiol Scand (1985) 0.97
Amplification of c-myc oncogene by chromogenic and fluorescence in situ hybridization in archival breast cancer tissue array samples. Lab Invest (2001) 0.97
Chronic esophagitis and gastric metaplasia are frequent late complications of esophageal atresia. J Pediatr Surg (1993) 0.97
Histological pattern and changes in extracellular matrix in aortic dissections. J Clin Pathol (1986) 0.96
Oncocytic cystadenoma of the parotid gland with tyrosine-rich crystals. Pathol Res Pract (2000) 0.96
92-kDa type IV collagenase and TIMP-3, but not 72-kDa type IV collagenase or TIMP-1 or TIMP-2, are highly expressed during mouse embryo implantation. Dev Dyn (1995) 0.96
Expression and prognostic value of transcription factor PROX1 in colorectal cancer. Br J Cancer (2011) 0.96
Laminins, tenascin and type VII collagen in colorectal mucosa. Histochem J (1996) 0.96
Other neurotrophic factors: glial cell line-derived neurotrophic factor (GDNF). Microsc Res Tech (1999) 0.95